Analyst firms · Barclays · HCA
Barclays HCA price target and rating history
HCA Healthcare Inc. (HCA) · Health Care
Barclays rates HCA Healthcare Inc. (HCA) Equal Weight with a $427 price target, as of its latest action on Jul 8, 2026. It has published 4 rating actions on HCA since July 2021, including 0 upgrades and 2 downgrades. Across 3 firms with a HCA price target in the last 12 months, the median target is $427. Barclays's target matches it.
- Current rating
- Equal Weight
- Price target
- $427
- Median target, all firms
- $427
- Actions on HCA
- 4
Barclays price target on HCA
Every Barclays rating on HCA
- Jul 8, 2026
- Mar 6, 2024
- Aug 12, 2021
- Jul 22, 2021
How other firms rate HCA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BMO Capital Markets | Outperform | $495 | Sep 23, 2026 |
| Barclays | Equal Weight | $427 | Jul 8, 2026 |
| Morgan Stanley | Underweight | $425 | Dec 15, 2025 |
Questions about Barclays and HCA
- What is Barclays's price target for HCA?
- Barclays's latest stated price target for HCA Healthcare Inc. (HCA) is $427, from its action on Jul 8, 2026.
- What is Barclays's rating on HCA?
- Barclays rates HCA Equal Weight, a neutral rating, as of Jul 8, 2026.
- When did Barclays last change its view on HCA?
- On Jul 8, 2026, Barclays downgrades to Equal Weight from Overweight, price target $427.
- How does Barclays's HCA target compare with other analysts?
- Across 3 firms with a HCA price target in the last 12 months, the median target is $427. Barclays's target matches it.
More HCA rating histories
All Barclays ratingsHCA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.